INSIGHTS ON DRUG DEVELOPMENT

• Using Human-Centered Engineering To Improve HPLC Solvent Handling

  Real-world HPLC workflows show how closed-system solvent handling can address contamination, downtime, and waste across laboratory settings.

• Assess Biomolecular Stability With Confidence

  Gain deeper insight into biomolecular stability with highly sensitive thermal analysis. Thermodynamic measurements help evaluate formulation performance, detect structural changes, and more.

• Application Of LC-UV/MS Workflows To Increase Efficiency

  Discover how LC-UV/MS workflows help overcome analytical challenges in GLP-1 analog development to streamline impurity identification and boost lab efficiency in research.

• Simplify And Streamline Method Development With In Silico Modeling

  Automated screening paired with in silico modeling can cut method development time while improving robustness. See how combining experimentation and simulation enables faster decision‑making.

• Bioprocess Training And Education

  3/17/2026

  Advance from development to manufacturing with expert-led, hands-on, or virtual courses that strengthen process understanding and scale-up skills designed to support every stage of your molecule’s journey.

• Improving Consumer Safety Through Innovative Science

  6/27/2025

  Liquid chromatography revolutionizes science with precision. Discover a technology that leads the charge in enhancing HPLC performance for breakthroughs in health, safety, and environmental research.

• Targeted Modalities Set Elevated Standards For Precision

  4/7/2026

  Explore how targeted modalities like ADCs and TPDs are transforming precision medicine, unlocking new treatment opportunities, and overcoming development challenges to improve patient outcomes.

• How Automation Helps Life Sciences Manufacturers Deliver Faster, Safer Therapies

  6/2/2026

  Automation paired with smart data management is becoming the base for faster drug and vaccine production without trading away quality. Five investment priorities show where manufacturers are concentrating their efforts.

• Linking Biomarkers To Clinical Proof-Of-Mechanism

  10/19/2026

  Proving CNS delivery and target engagement in neurodegenerative therapies requires aligned clinical pharmacology and bioanalysis, from model selection to validated assays.